NASDAQ: CBRSCerebras Systems Inc Stock
$296.65+16.69 (+5.96%)
Updated May 18, 2026
CBRS Price
$296.65
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$272.24
52 Week High
$386.34
P/E
180.88x
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$509.99M
Earnings
$237.83M
Gross Margin
39%
Operating Margin
48.02%
Profit Margin
17.2%
Debt to Equity
-1.68
Operating Cash Flow
-$10M
Beta
13.73
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CBRS Overview
Cerebras Systems Inc. operates as an artificial intelligence infrastructure company. It designs and manufactures an AI compute platform that comprises of proprietary systems and software that is delivered in racks for deployment in data centers up to supercomputer scale. The company's pioneering wafer-scale engine, a chip encompassing a silicon wafer, designed to enable higher performance and speeds than GPUs for the computational demands of inference, Generative AI, and other AI applications. Its customers include hyperscalers, foundation model labs, AI-native and digital-native businesses, enterprises, and leaders of Sovereign AI initiatives. The company has operations in the United States, Europe, the Middle East, Africa, and internationally. Cerebras Systems Inc. was founded in 2015 and is headquartered in Sunnyvale, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CBRS's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Semiconductor
Industry Rating
B
CBRS
Ranked#61 of 68
Ranked#61 of 68
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $681.54 | A | |
| $239.76 | A | |
| $41.35 | A |
Be the first to know about important CBRS news, forecast changes, insider trades & much more!
CBRS News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CBRS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CBRS is poor value based on its earnings relative to its share price (180.88x), compared to the US market average (23.29x)
P/E vs Market Valuation
CBRS is poor value based on its earnings relative to its share price (180.88x), compared to the US Semiconductors industry average (49.22x)
P/E vs Industry Valuation
CBRS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more CBRS due diligence checks available for Premium users.
Valuation
CBRS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
180.88x
Industry
49.22x
Market
23.29x
CBRS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CBRS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CBRS's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
CBRS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CBRS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.3B
Liabilities
$971.3M
Debt to equity
-1.68
CBRS's short-term assets ($1.54B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CBRS's short-term assets ($1.54B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CBRS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CBRS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
CBRS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CBRS vs Semiconductor Stocks
Cerebras Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.